YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
@article{Marti2015YAPPP,
title={YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors},
author={Patricia Marti and Claudia Stein and Tanja Blumer and Yann Abraham and Michael T. Dill and Monika Pikiolek and Vanessa Orsini and Giorgia Jurisic and Philippe Megel and Zuzanna Makowska and Claudia Agarinis and Luigi Tornillo and Tewis Bouwmeester and Heinz Ruffner and Andreas Bauer and Christian N. Parker and Tobias Schmelzle and Luigi M. Terracciano and Markus Hermann Heim and Jan S. Tchorz},
journal={Hepatology},
year={2015},
volume={62}
}The Yes‐associated protein (YAP)/Hippo pathway has been implicated in tissue development, regeneration, and tumorigenesis. However, its role in cholangiocarcinoma (CC) is not established. We show that YAP activation is a common feature in CC patient biopsies and human CC cell lines. Using microarray expression profiling of CC cells with overexpressed or down‐regulated YAP, we show that YAP regulates genes involved in proliferation, apoptosis, and angiogenesis. YAP activity promotes CC growth in…
Topics from this paper
131 Citations
A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma*
- Biology, MedicineThe Journal of Biological Chemistry
- 2016
Preclinical data suggest not only that the YAP and Hippo signaling pathways culminate in an Mcl-1-regulated tumor survival pathway but also that nuclear YAP expression may be a biomarker to employ in FGFR-directed therapy.
STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling
- BiologyCancer science
- 2019
It is reported that the E3 ubiquitin ligase STUB1 ubiquitinates and destabilizes YAP1, thereby inhibiting cancer cell survival and providing a rationale for potential therapeutic interventions in gastric cancer.
YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
- Biology, ChemistryCell Death & Disease
- 2018
YAP1 is a driver of NSCLC metastasis because YAP1 promoted the EMT program by inducing Slug transcription, and silencing Yap1 inhibited A549 cell tumorigenesis and EMT and downregulated Slug expression in vivo.
miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
- Biology, MedicineEBioMedicine
- 2018
YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression
- Biology, MedicineCell death & disease
- 2021
It is found that YAP could negatively regulate autophagy in CRC cells, and consequently, promote tumor progression of CRC in vitro and in vivo and provides evidence for YAP/Bcl-2 as a potential therapeutic target for drug exploration against CRC.
YAP orchestrates heterotypic endothelial cell communication via HGF/c-MET signaling in liver tumorigenesis
- Biology, Medicine
- 2020
YAP-dependent changes of the liver vascular niche comprise the formation of heterologous communication hubs (e.g. the HGF/c-Met axis), in which tumor cell-derived factors modify the crosstalk between LSECs and CECs.
The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma.
- Biology, MedicineThe American journal of pathology
- 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
- Biology, MedicineThe American journal of pathology
- 2019
YAP-associated chromosomal instability and cholangiocarcinoma in mice
- Biology, MedicineOncotarget
- 2018
Preclinical data imply a role for YAP-mediated chromosomal instability in cholangiocarcinoma, and suggest FOXM1 inhibition as a therapeutic target for CCA.
TEAD4 promotes tumor development in patients with lung adenocarcinoma via ERK signaling pathway.
- Biology, MedicineBiochimica et biophysica acta. Molecular basis of disease
- 2020
References
SHOWING 1-10 OF 52 REFERENCES
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
- Biology, MedicineGastroenterology
- 2013
The transcriptional regulator YAP up-regulates Jag-1 to activate Notch signaling in HCC cells and mouse hepatocytes, suggesting the use of YAP and Notch inhibitors as therapeutics for gastrointestinal cancer.
YAP activation is an early event and a potential therapeutic target in liver cancer development.
- Biology, MedicineJournal of hepatology
- 2014
Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
- Medicine, BiologyGastroenterology
- 2014
BACKGROUND & AIMS
Aberrant activation of β-catenin and Yes-associated protein 1 (Yap1) signaling pathways have been associated with the development of multiple tumor types. Yap functions as a…
YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells
- BiologyCurrent Biology
- 2007
Yes-associated protein (YAP) functions as a tumor suppressor in breast
- Biology, MedicineCell Death and Differentiation
- 2008
This is the first report indicating YAP as a tumor suppressor, revealing its decreased expression in breast cancer as well as demonstrating the functional implications of YAP loss in several aspects of cancer signaling.
TEAD mediates YAP-dependent gene induction and growth control.
- BiologyGenes & development
- 2008
TEAD is revealed as a new component in the Hippo pathway playing essential roles in mediating biological functions of YAP, and is required for YAP-induced cell growth, oncogenic transformation, and epithelial-mesenchymal transition.
Constitutive Notch2 signaling induces hepatic tumors in mice
- Biology, MedicineHepatology
- 2013
It is shown that liver‐specific expression of the intracellular domain of Notch2 (N2ICD) in mice is sufficient to induce HCC formation and biliary hyperplasia, and an oncogenic role for constitutive Notch 2 signaling in liver cancer development is established.
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.
- BiologyGenes & development
- 2010
New insights are provided into the Hippo signaling pathway, elucidating novel phosphorylation-dependent and independent mechanisms of YAP/Yki inhibition by the hippo pathway, new Hippo pathway components, novel YAP target transcription factors and target genes, and the three-dimensional structure of the YAP-TEAD complex, and providing further evidence for the involvement of Y AP and the Hippi pathway in tumorigenesis.